AmphetamineAmphetaminesCentral Nervous System StimulantsDextroamphetamineIodine RadioisotopesAmphetamine-Related DisordersDose-Response Relationship, DrugMethamphetamineAcetaminophenDrug InteractionsSubstance Abuse DetectionMiosisAdministration, OralRadioimmunotherapyAnalgesics, Non-NarcoticN-Methyl-3,4-methylenedioxyamphetamineMethylphenidateRadiotherapy DosageTime FactorsDopamineRats, Sprague-DawleyDouble-Blind MethodVitamin K Epoxide ReductasesRadiometryWhole-Body CountingHalf-LifeStereotyped Behavior3,4-MethylenedioxyamphetamineNucleus AccumbensMotor ActivityDopamine AgentsBehavior, AnimalHistamine H1 AntagonistsCross-Over StudiesPhenylbutazoneBiological AvailabilityArea Under CurveGas Chromatography-Mass SpectrometryDrug Administration ScheduleDopamine Uptake InhibitorsStreet DrugsTissue DistributionInjections, IntravenousDesigner DrugsBenzodiazepinesCocaineAnticonvulsantsTreatment OutcomeAppetite DepressantsRats, WistarAntipsychotic AgentsWarfarinDopamine Plasma Membrane Transport ProteinsThyroid NeoplasmsHypnotics and SedativesCorpus StriatumLeukemia L1210AnticoagulantsDisease Models, AnimalDose-Response Relationship, RadiationDrug HypersensitivityChromatography, High Pressure LiquidHallucinogensAryl Hydrocarbon HydroxylasesBrainValproic AcidPiperazinesMetabolic Clearance RateAnalysis of VarianceRadiopharmaceuticalsAnti-Inflammatory Agents, Non-Steroidal3-IodobenzylguanidineEnzyme Multiplied Immunoassay TechniqueForensic MedicineSerotonin Uptake InhibitorsSulfonesAntibodies, MonoclonalDopamine AgonistsBiotransformationDrug CombinationsPlacebosp-ChloroamphetamineLithiumAntineoplastic AgentsAdrenergic Uptake InhibitorsDopamine AntagonistsMethyltyrosinesMixed Function OxygenasesPyridinesNeostriatumReceptors, Dopamine D2NomifensinePyrazolonesPhenmetrazineEphedrineMicrodialysisDrug Therapy, CombinationLiverConditioning, OperantFenfluramine